Quitlines may double as lung cancer screening boosters

NCT ID NCT07720141

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This study compares two ways to share lung cancer screening information with people who call tobacco quitlines. Participants are quitline clients aged 50 to 80 with a heavy smoking history. One approach offers extra coaching and navigation support. The goal is to see which method leads to more people getting screened.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
behavioral intervention: high-touch strategy (educational materials, decision coaching, navigation)
What this could lead to
If successful, this could provide a scalable method to increase lung cancer screening among people who smoke, potentially catching cancers earlier.
What could go wrong
This is a behavioral study without a drug, so the impact may be modest. Results depend on quitline clients' willingness to engage, and screening rates may not change significantly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UT MD Anderson

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.